Smith & Nephew (NYSE:SNN) Cut to Hold at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew (NYSE:SNN - Free Report) from a buy rating to a hold rating in a research note published on Friday, MarketBeat reports.

Separately, StockNews.com upgraded Smith & Nephew from a "buy" rating to a "strong-buy" rating in a report on Monday, August 5th. Two research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Smith & Nephew presently has a consensus rating of "Moderate Buy".

Smith & Nephew Trading Up 0.6 %

Shares of NYSE:SNN traded up $0.15 during midday trading on Friday, reaching $25.24. 1,065,614 shares of the company's stock were exchanged, compared to its average volume of 863,465. The firm's 50 day simple moving average is $30.09 and its two-hundred day simple moving average is $27.78. Smith & Nephew has a fifty-two week low of $23.24 and a fifty-two week high of $31.72. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63.

Hedge Funds Weigh In On Smith & Nephew

Large investors have recently bought and sold shares of the business. Lorne Steinberg Wealth Management Inc. boosted its holdings in shares of Smith & Nephew by 53.6% in the 2nd quarter. Lorne Steinberg Wealth Management Inc. now owns 231,045 shares of the medical equipment provider's stock valued at $5,725,000 after buying an additional 80,650 shares in the last quarter. Clearbridge Investments LLC acquired a new position in Smith & Nephew during the first quarter worth approximately $2,612,000. Sanctuary Advisors LLC acquired a new stake in shares of Smith & Nephew in the second quarter valued at approximately $627,000. Tocqueville Asset Management L.P. boosted its holdings in shares of Smith & Nephew by 294.9% in the first quarter. Tocqueville Asset Management L.P. now owns 224,441 shares of the medical equipment provider's stock valued at $5,692,000 after acquiring an additional 167,599 shares during the period. Finally, Bank of Montreal Can grew its position in shares of Smith & Nephew by 355.8% during the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider's stock worth $31,059,000 after acquiring an additional 964,762 shares during the last quarter. Hedge funds and other institutional investors own 25.64% of the company's stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.